Skip to main content
. 2019 Nov 12;15:3167–3176. doi: 10.2147/NDT.S214976

Figure 2.

Figure 2

SMYZ treatment on learning and memory deficits induced by scopolamine.

Notes: (A) The effects of SMYZ on the escape latency in the MWM test after 4-week treatment in rats, including (A) P < 0.01, control group versus model group; (B) P < 0.01, SMYZ-H group versus model group. (B) The number of crossing over the platform position during the spatial probe test in the MWM test on the fifth day, * P < 0.05, versus the model group. (C) The percent of swimming distance in target quadrant during the spatial probe test in the MWM test on the fifth day, * P < 0.05, versus the model group. (D) The percent of swimming time in target quadrant during the spatial probe test in the MWM test on the fifth day, * P < 0.05, versus model group. Data are expressed as mean ± SEM (n=10).

Abbreviations: SMYZ, Shenmayizhi decoction; SMYZ-L, low-concentration SMYZ group; SMYZ-M, medium-concentration SMYZ group; SMYZ-H, high-concentration SMYZ group.